Kraig Biocraft Laboratories, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OQB
Kraig Biocraft Laboratories has entered into a $10 million Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD. to support the expansion and commercialization of its spider silk production.
OQB
Kraig Biocraft Laboratories issued one share of Series A preferred stock to its CEO, Kim Thompson, in exchange for $20,000 of debt cancellation.